TennesseeLifeScience.com

Welcome to TennesseeLifeScience.com

TennesseeLifeScience.com is part of a specialized network of state- and province-based biotechnology, medical device, and life science sites that includes more than 4,500 biotechnology, medical device, pharmaceutical companies, non-profit research institutions, universities and supporting service sector companies across the U.S. and Canada.

This network addresses the growing informational and service needs of companies, patients, educators and others in their respective states while providing clients the opportunity to cost effectively advertise their job openings, events, facility availability and other services at the state level, regionally or nationwide. We welcome your comments, suggestions and requests for informational content and supporting services.

More...

Destination Tennessee

Are you considering a move to Tennessee? Relocating your business to Tennessee? Starting a company? Or just interested in Tennessee?

This section will answer many of your questions regarding the life science industry in Tennessee, the province's economy, tax structure and cost of living, education, transportation, climate, recreational opportunities, history, industry resources, and more.

More...

Local News...

Free News Release Posting & Archiving Service

FDA approves tapentadol immediate-release tablets for relief of acute pain Johnson & Johnson Pharmaceutical Research & Development, announced that the U.S. Food and Drug Administration (FDA) approved tapentadol immediate-release tablets for the relief of moderate to severe acute pain in adults 18 years of age or older.
Johnson & Johnson November 21, 2008
New antibiotic against serious infections The Committee for Medicinal Products for Human Use (CHMP) has recommended approval for the antibiotic, ZEVTERA(TM) (ceftobiprole medocaril) for the treatment of complicated skin and soft tissue infections.
Johnson & Johnson November 21, 2008
EMEA recommends suspension of marketing authorisation for IONSYS(R) Janssen-Cilag International NV announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has recommended suspension of the marketing authorisation for IONSYS(R), indicated for the management of pain for use in a hospital setting only.
Johnson & Johnson November 21, 2008
Independent scientists determine study conclusions are flawed On November 11, 2008, the Austrian Ministry of Health, Family and Youth released a report on three studies designed to assess the impact of GM corn on reproduction. One finding in one of the studies was interpreted as a possible impact on reproduction in the test mice.
Monsanto Company November 21, 2008
Nplate(TM) (Romiplostim) receives positive opinion for marketing authorisation in the EU Amgen announced that the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending marketing authorisation for Nplate(TM) (romiplostim) in the European Union (EU).
Amgen November 21, 2008

More... | Submit News Release | National News

New Job Postings...

Free Job Posting Trial Offer

Clinical Research Coordinator I Benaroya Research Institute (WA)
Postdoctoral Research Associate Benaroya Research Institute (WA)
Postdoctoral Research Associate Benaroya Research Institute (WA)
Employee Health and Safety Site Manager GlaxoSmithKline (MT)
Production Manager II Bio-Rad Laboratories, Inc. (WA)

More... | Job Advertising... | About Job Postings...

New Facilities Available...

ATC clean room constructors...validation guaranteed!

890 Embarcadero Road Property -- West Sacramento, CA
Epigenomics Lab/Office Space -- Seattle, WA
Life Sciences Incubator -- Seattle, WA
University of Iowa Oakdale Research Park Biotech Building -- Coralville, IA
University of Iowa Oakdale Research Park BioVentures Center -- Coralville, IA

More... | Facility Advertising...

Upcoming Events...

Free Event Posting Service

11/24/2008: Test Method Validation Basics - Ensuring
11/24/2008: Current GMP and GCP Compliance Trends
11/25/2008: The IDE (Investigational Device Exemption) - It's Purpose and Preparation
11/25/2008: Best Practices in GLP Final Reporting and Study Closure
11/25/2008: Regulatory requirements on pharmaceutical packaging materials from US and EU points of view

More... | Submit Event | Event Advertising...

Learn About Tennessee's BioHistory

Why is there a biotechnology industry in Tennessee? Will the industry continue to grow in Tennessee? What do other states have? Each state has a unique story that explains why a given industry has developed in a specific region and not in others.

Through Tennessee BioHistory, you can learn about the scientists, institutions, political leaders, and significant events that have shaped and are still shaping the biotechnology, medical device and life science industries in the state of Tennessee.

More...

BioEvolution Posters

More...

November is American Diabetes Month

Diabetes is a leading cause of kidney failure, blindness and amputations, and a major cause of heart disease and stroke. Nearly 24 million Americans have diabetes, and about one quarter (or 5.7 million) of them don't know that they have the disease. Millions more are at risk of developing diabetes.

Diabetes is a costly disease associated with serious complications and premature death. It is a major cause of heart disease and stroke and a leading cause of leg and foot amputations unrelated to injury, kidney failure, and new blindness in adults.

More...